
Circle Neurovascular Imaging
Enhancing the acute stroke pathway through a simple, pragmatic approach to image interpretation and team collaboration.
USD | 2022 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
% growth | - | (83 %) |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Circle Neurovascular Imaging (NVI) operates as a subsidiary of Circle Cardiovascular Imaging, a specialist in medical imaging software. The company was founded in September 2019 through a collaboration between members of the Calgary Stroke Program and Circle Cardiovascular Imaging. The founders include prominent stroke researchers Dr. Michael Hill, Dr. Bijoy Menon, and Dr. Andrew Demchuk, who leveraged their deep clinical expertise in stroke care. This venture was established to apply artificial intelligence to the critical and time-sensitive field of stroke diagnosis and treatment.
Circle NVI's core business revolves around its AI-powered medical imaging software, StrokeSENS™. This platform is designed to serve hospital networks and trained medical professionals by augmenting the analysis of acute stroke images. The business model likely involves licensing this software to healthcare institutions, providing them with a tool to improve diagnostic speed and accuracy. The company generates revenue through these software licenses and associated services, targeting a market where rapid decision-making directly impacts patient outcomes. The company has established significant partnerships, including a deal with GE Healthcare to implement its technology across its health systems.
The StrokeSENS™ software offers several key features to frontline clinicians. It uses AI algorithms to analyze non-contrast CT (NCCT) and CT Angiography (CTA) scans to quickly identify signs of a stroke, such as large vessel occlusions (LVO). The platform provides automated notifications and communication capabilities, instantly sharing critical information with designated members of a stroke team to facilitate faster, more coordinated treatment decisions. This functionality is particularly valuable in remote and rural areas where specialized expertise may be limited. The technology has received regulatory clearances, including from Health Canada, the FDA in the United States, and CE Mark in Europe, underscoring its clinical validation.
Keywords: neurovascular imaging, stroke diagnosis, medical imaging software, artificial intelligence in healthcare, AI-powered diagnostics, large vessel occlusion, CT scan analysis, StrokeSENS, acute stroke care, clinical decision support, radiological software, medtech, Health Canada clearance, FDA clearance, Calgary Stroke Program, image processing, healthcare technology systems, remote stroke care, telestroke, triage software